whether it's filed or not, the share outstanding should have been reduced by 150M after it was returned to the treasury, unless there was some sort of delay or those officers and directors still cling onto those shares. news on 2/14/2012:
Solos Endoscopy, Inc. (OTCPK: SNDY) announced today that the Company's Board of Directors has completed the retirement of one hundred fifty million (150,000,000) common shares held by its officers and directors in exchange for Series B Convertible Preferred Shares. The common shares held by the officers and directors have now been cancelled and returned back to the Company treasury.